These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 493313)

  • 21. Study design and statistical analysis of toxicokinetics: a report of JPMA investigation of case studies.
    Igarashi T; Yabe T; Noda K
    J Toxicol Sci; 1996 Dec; 21(5):497-504. PubMed ID: 9035061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical scientist's view of preclinical drug testing requirements.
    Dayan AD
    Hum Exp Toxicol; 1991 Nov; 10(6):395-7. PubMed ID: 1687848
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro approaches in developmental toxicology.
    Schwetz BA
    Reprod Toxicol; 1993; 7 Suppl 1():125-7. PubMed ID: 8400631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.
    Sewell F; Chapman K; Baldrick P; Brewster D; Broadmeadow A; Brown P; Burns-Naas LA; Clarke J; Constan A; Couch J; Czupalla O; Danks A; DeGeorge J; de Haan L; Hettinger K; Hill M; Festag M; Jacobs A; Jacobson-Kram D; Kopytek S; Lorenz H; Moesgaard SG; Moore E; Pasanen M; Perry R; Ragan I; Robinson S; Schmitt PM; Short B; Lima BS; Smith D; Sparrow S; van Bekkum Y; Jones D
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):413-29. PubMed ID: 25078890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation to phoniatrics to endocrinology].
    Bauer H
    Folia Phoniatr (Basel); 1968; 20(6):387-93. PubMed ID: 5719834
    [No Abstract]   [Full Text] [Related]  

  • 26. A network solution.
    Henney A; Superti-Furga G
    Nature; 2008 Oct; 455(7214):730-1. PubMed ID: 18843342
    [No Abstract]   [Full Text] [Related]  

  • 27. Methodological innovations expand the safety pharmacology horizon.
    Pugsley MK; Curtis MJ
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction to expert opinion on endocrine complications of new anticancer therapies.
    Castinetti F; Borson-Chazot F
    Ann Endocrinol (Paris); 2018 Oct; 79(5):535-538. PubMed ID: 30056976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity approaches in the screening of environmental agents for developmental toxicity.
    Kavlock RJ
    Reprod Toxicol; 1993; 7 Suppl 1():113-6. PubMed ID: 8400629
    [No Abstract]   [Full Text] [Related]  

  • 30. Guideline limit volumes for dosing animals in the preclinical stage of safety evaluation. Toxicology Subcommittee of the Association of the British Pharmaceutical Industry.
    Hull RM
    Hum Exp Toxicol; 1995 Mar; 14(3):305-7. PubMed ID: 7779463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction: The ecological relevance of chemically induced endocrine disruption in wildlife.
    Jobling S; Tyler CR
    Environ Health Perspect; 2006 Apr; 114 Suppl 1(Suppl 1):7-8. PubMed ID: 16818239
    [No Abstract]   [Full Text] [Related]  

  • 32. Symposium on Present Status and Goals of Collaborative Studies in Toxicology. 92nd Annual Meeting of the AOAC, October 1978.
    J Assoc Off Anal Chem; 1979 Jul; 62(4):832-916. PubMed ID: 40949
    [No Abstract]   [Full Text] [Related]  

  • 33. Perspectives on testing for toxic agents.
    Nelson N
    Environ Health Perspect; 1987 Nov; 75():97-103. PubMed ID: 3319572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The common marmoset (Callithrix jacchus) as a model in toxicology.
    Zühlke U; Weinbauer G
    Toxicol Pathol; 2003; 31 Suppl():123-7. PubMed ID: 12597440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early ADME/Tox studies and in silico screening.
    Li AP; Segall M
    Drug Discov Today; 2002 Jan; 7(1):25-7. PubMed ID: 11790599
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug discrimination in behavioral toxicology.
    Colpaert FC
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):48-51. PubMed ID: 3124387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncertainty factors in noncancer risk assessment.
    Dourson M
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):107. PubMed ID: 8933623
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxicology in the drug discovery and development process.
    Dorato MA; Buckley LA
    Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.3. PubMed ID: 22294168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human and laboratory animal test systems available for detection of reproductive failure.
    Manson JM
    Prev Med; 1978 Sep; 7(3):322-31. PubMed ID: 733731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.